Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Diet-induced adipose tissue expansion is mitigated in mice with a targeted inactivation of mesoderm specific transcript (Mest)

Abstract

Interindividual variation of white adipose tissue (WAT) expression of mesoderm specific transcript (Mest), a paternally-expressed imprinted gene belonging to the α/β-hydrolase fold protein family, becomes apparent among genetically inbred mice fed high fat diet (HFD) and is positively associated with adipose tissue expansion (ATE). To elucidate a role for MEST in ATE, mice were developed with global and adipose tissue inactivation of Mest. Mice with homozygous (MestgKO) and paternal allelic (MestpKO) inactivation of Mest were born at expected Mendelian frequencies, showed no behavioral or physical abnormalities, and did not perturb expression of the Mest locus-derived microRNA miR-335. MestpKO mice fed HFD showed reduced ATE and adipocyte hypertrophy, improved glucose tolerance, and reduced WAT expression of genes associated with hypoxia and inflammation compared to littermate controls. Remarkably, caloric intake and energy expenditure were unchanged between genotypes. Mice with adipose tissue inactivation of Mest were phenotypically similar to MestpKO, supporting a role for WAT MEST in ATE. Global profiling of WAT gene expression of HFD-fed control and MestpKO mice detected few differences between genotypes; nevertheless, genes with reduced expression in MestpKO mice were associated with immune processes and consistent with improved glucose homeostasis. Ear-derived mesenchymal stem cells (EMSC) from MestgKO mice showed no differences in adipogenic differentiation compared to control cells unless challenged by shRNA knockdown of Gpat4, an enzyme that mediates lipid accumulation in adipocytes. Reduced adipogenic capacity of EMSC from MestgKO after Gpat4 knockdown suggests that MEST facilitates lipid accumulation in adipocytes. Our data suggests that reduced diet-induced ATE in MEST-deficient mice diminishes hypoxia and inflammation in WAT leading to improved glucose tolerance and insulin sensitivity. Since inactivation of Mest in mice has minimal additional effects aside from reduction of ATE, an intervention that mitigates MEST function in adipocytes is a plausible strategy to obviate obesity and type-2-diabetes.

Citation: Anunciado-Koza RP, Manuel J, Mynatt RL, Zhang J, Kozak LP, Koza RA (2017) Diet-induced adipose tissue expansion is mitigated in mice with a targeted inactivation of mesoderm specific transcript (Mest). PLoS ONE 12(6): e0179879. https://doi.org/10.1371/journal.pone.0179879

Editor: Josep A. Villena, Vall d'Hebron Institut de Recerca, SPAIN

Received: April 16, 2017; Accepted: June 6, 2017; Published: June 22, 2017

Copyright: © 2017 Anunciado-Koza et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All data are contained within the paper, Supporting Information files, and held in the public repository Gene Expression Omnibus (GEO; accession number: GSE96968).

Funding: Studies were funded by NIDDK RO1DK090361 (R.A.K). Support was also provided by the Molecular Phenotyping and the Physiology Core Facilities at Maine Medical Center Research Institute funded by COBRE (NIGMS P30GM106391), the Viral Vector Core at Maine Medical Center Research Institute funded by COBRE (NIGMS P30GM103392), and the Genomics, Cell Biology and Imaging, and Transgenic Core facilities at Pennington Biomedical Research Center funded in part by COBRE (NIGMS P20GM103528) and NORC (NIDDK P30DK072476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

The global rise in obesity rates are caused by interactions between an individual’s genetic predisposition, the environment and epigenetic factors. The genetic component has been clearly demonstrated in studies of monozygotic twins with heredity predicted to account for ~40–70% of obesity [1, 2]. However, recent genome wide association studies (GWAS) of 97 body mass index (BMI)-associated loci in >300K individuals was shown to account for only <3% of the variance of BMI [3]. Although it is estimated that risk alleles may account for up to ~20% of this variance [3], a large percentage of BMI is unexplained which underscores the complexity of interactions between genomic, environmental and epigenetic components [4–6]. Therefore, the use of murine models in which the genetic background and environment can be carefully controlled is a powerful tool for the identification of potential epigenetic determinants associated with the development of obesity and related disease.

Variable development of diet-induced obesity (DIO) and type 2-diabetes (T2D) within inbred populations of mice has been well described [7–11] and shown to be stable among individual animals which suggests that an epigenetic mechanism is likely involved in its etiology [10, 12, 13]. Analyses of gene expression in white adipose tissue (WAT) of inbred C57BL/6J mice that showed diversity in DIO identified a novel set of genes that correlate with fat mass accretion [10, 13–16]. Mesoderm specific transcript (Mest), a maternally imprinted gene, showed variations of mRNA up to ~80-fold in WAT from individual mice fed an obesogenic diet which was positively associated with the rate of fat mass deposition [10, 16]. In addition, Mest mRNA in WAT biopsies prior to feeding mice an obesogenic diet was predictive of future inter-individual development of DIO [10]. Compelling evidence for a role for Mest in facilitating fat accumulation was obtained by transgenic overexpression of Mest in cell culture and in mouse adipose tissue; and, in the analyses of Mest gene and protein in WAT during developmental growth and in adult mice fed dietary fat [7, 10, 13, 14, 16–20]. Recent studies have determined that adipose tissue as well as blood levels of Mest mRNA is a rapid and early biological indicator of adipose tissue expansion (ATE) in mice [21]. ATE, or fat mass expansion, is a characteristic of obesity caused predominantly by triglyceride storage and expansion of adipocytes (i.e. adipocyte hypertrophy), and to a lesser extent, increased adipocyte hyperplasia [22, 23].

The positive association of Mest with ATE has been well established; however, little is known in regards to the catalytic function of MEST and whether its activity directly contributes to adipocyte hypertrophy and/or adipose tissue remodeling. MEST belongs to the α/β-hydrolase family of proteins [24, 25] and contains the catalytic triad serine-histidine-aspartate (amino acids 145–147) which is commonly associated with serine proteases, lipases and acyltransferases [24, 26]. Evidence showing that MEST is localized within the endoplasmic reticulum/Golgi apparatus of the adipocyte further supports its function in the facilitation of fat storage in adipocytes [16, 20, 27]. Alternatively, MEST contains a conserved epoxide-coordinating tyrosine in its sequence and shows sequence similarity to epoxide hydrolases from M. tuberculosis [28, 29]. Epoxide hydrolases modulate levels of epoxy fatty acids and their diol derivatives which have been shown to act as endogenous mediators of PPARs alpha and gamma [30–34]. Studies have shown that epoxyeicosatrienoic acid (EET) analog treatment suppresses adipogenesis of 3T3-L1 preadipocytes and reduces ATE and improves glucose tolerance in mice fed a high fat diet [35]. It has been suggested that mitigation of adipogenic differentiation by EET may occur via Pgc1α-dependent activation of the heme oxygenase-1 (Hmox1)-pAKT signaling pathway [36, 37]. Other studies suggest that Mest may act to attenuate Wnt signaling in 3T3-L1 cells by inhibiting the maturation and exit of LRP6 from the endoplasmic reticulum by controlling its glycosylated state [27].

In adult mice, MEST protein is highly expressed in white adipose tissue with very little or undetectable expression observed in brown adipose tissue, whole brain, liver, heart, kidney and spleen [16]. Recent studies suggest that human MEST could be an epigenetic target for periconceptual or intrauterine environmental exposures, such as parental obesity and gestational diabetes, leading to changes in its methylated state [38, 39]. Although few studies have examined MEST with respect to human adipose tissue, it has been shown that MEST is induced during adipogenesis of isolated human adipocytes [40, 41] and human abdominal subcutaneous white adipose tissue biopsies show increased MEST mRNA in obese compared to non-obese individuals [41].

In this study we generated isogenic mouse models with both global and conditional targeted inactivation of Mest to investigate its role in adipose tissue development and expansion. Our data suggests that MEST contributes to ATE by facilitating lipid accumulation in adipocytes in an obesogenic environment thereby enhancing hypoxia and inflammation which lead to impaired glucose tolerance and insulin sensitivity.

Results

Validation of gene targeted Mest knockout mice

A targeting vector containing a neomycin (NEO) selection cassette was used to insert loxP sites immediately 5’ and 3’ of Mest exon 3 using C57BL/6J (B6) ES cells (Fig 1A). Subsequent breeding of mice with germline transmission of the targeted Mest allele with Ella-cre transgenic mice resulted in the selection of progeny with deletions of only the NEO cassette or the floxed region (NEO cassette and Mest exon 3) resulting in an intact floxed or a global deletion of Mest exon 3. Deletion of exon 3 of Mest creates a stop codon in exon 4 and full inactivation of Mest as shown by the absence of Mest mRNA in white adipose tissue (WAT) of homozygous knockout (MestgKO) mice (Fig 1B). Mest, an imprinted gene that is almost exclusively expressed from the paternal allele in adult mice [42–45] and highly expressed in WAT [10, 16, 46], is completely abrogated in mice with a paternal allelic inactivation of Mest (MestpKO), but shows fully intact mRNA and protein levels when the maternal allele of Mest is selectively inactivated (MestmKO; Fig 1B and 1C). Unlike previous observations showing abnormal maternal behavior and high incidence of postnatal mortality in mice with global or paternal inactivation of Mest on a mixed B6/129 background (Lefebvre et al 1998), our studies indicate normal litter sizes reared by dams with inactivated Mest (~8.2 pups/litter); and non-skewed gender (29 female/30 male) and genotype ratios with 14 wildtype (WT), 30 MestmKO or MestpKO and 15 MestgKO (chi-square 0.119; P = 0.998) born from crosses between heterozygous females and males. The basis for phenotypic differences in maternal behavior and early post-natal mortality between our studies and those of Lefebvre et al 1998 [43] are not known.

thumbnail
Download:
Fig 1. Validation of targeted Mest allele.

(A) Representation of the targeted allele for mesoderm specific transcript (Mest) with loxP sites flanking Mest exon 3 and a Neo cassette located in intron 2. Deletion of Mest exon 3 causes a frameshift mutation and the generation of a stop codon (indicated with a hexagon containing an ‘S’) in Mest exon 4. (B) Analyses of Mest mRNA in adipose tissue of wildtype (WT; n = 3) mice and mice with homozygous (gKO; n = 3), maternal (mKO; n = 3) and paternal (pKO; n = 3) allelic inactivation of Mest by qRT-PCR showed complete loss of mRNA in adipose tissue of Mest gKO and pKO mice. (C) Western blot analysis shows MEST protein in adipose tissue of 2 mice with maternal allele inactivation of Mest (mKO1 and mKO2) whereas MEST protein is completely absent in adipose tissue of mice with a paternal allele inactivation of Mest (pKO). (D) Representation of the Mest gene showing location of miR-335 near the proximal loxP site of the targeted Mest allele and 3 known splice variants (TV1, TV2 and TV3) for murine Mest. Small bars located above and below the diagram indicate the approximate location of forward reverse primers used to measure relative levels of each variant in adipose tissue. (E) QRT-PCR analyses of Mest and miR-335 expression in total RNA isolated from 4–7 iWAT depots for each of 4 genotypes of 6–7 day old mice indicates that deletion of Mest exon 3 has minimal effect on miR-335 expression. Levels of Mest and miR-335 expression are presented as the mean ± SEM. (F) RT-PCR analyses for 30 and 25 cycles indicates that transcript variant 2 (TV2; NM_008590.2) is the predominant Mest isoform in both epididymal white adipose tissue (eWAT) and inguinal white adipose tissue (iWAT). Sizes of PCR products for each of the transcript variants and TATA-box binding protein (Tbp) are shown on the right hand side of the figure.

https://doi.org/10.1371/journal.pone.0179879.g001

Since the Mest locus harbors a microRNA (miR-335), which has also been implicated in adipogenesis and lipid metabolism [47, 48], within an intronic sequence between exons 2 and 3 of Mest transcript variant 2 (TV2), an analyses was performed to determine whether the close proximity of a loxP site (Fig 1D) from the targeting vector aberrantly affects expression of miR-335. Analyses of inguinal (iWAT) WAT of 6–7 day old mice, a developmental time period when fat mass is rapidly expanding and WAT Mest is highly expressed [16], showed no differences in miR-335 expression in mice with intact (WT and MestmKO) versus inactivated (MestgKO and MestpKO) Mest (Fig 1E). In addition, RT-PCR analyses of 3 known transcriptional variants of Mest in mice that vary in the use of alternative exons (Fig 1D) shows that transcript variant 2 (TV2; NM_008590.2) is predominantly expressed in both subcutaneous iWAT and visceral epididymal (eWAT) WAT depots (Fig 1F). Mest TV1, which uses an additional alternative exon in the 5’ coding region compared to TV2, also shows a low level of expression in WAT, whereas TV3, a variant of Mest mRNA that uses an alternative 5’UTR ~4.5 kb upstream from the 5’UTR containing exon of TV1 and TV2, was absent in WAT (Fig 1F).

Bodyweight and body composition

Since MestpKO mice do not express Mest mRNA or protein in WAT (Fig 1B and 1C), male progeny (WT and MestpKO) for the dietary obesity study were generated from a cross between female WT and male MestmKO mice. From weaning (week 3) until 8 weeks of age, MestpKO mice showed a small but significant reduction in body weight (Fig 2A) but no differences in adiposity measured as the ratio of fat mass/lean mass (Fig 2B) compared to WT littermate controls. However, when fed an obesogenic diet (58 kcal% fat) from 8 until 16 weeks of age, dietary fat-induced increases in bodyweight, adiposity and fat mass deposition in MestpKO mice was significantly attenuated compared to WT mice (Fig 2A, 2B and 2C) whereas fat free mass (FFM) was unaffected (Fig 2C; inset). Regression analyses of the 17 WT mice at 16 weeks of age showed a strong correlation between eWAT Mest mRNA and fat mass deposition (R = 0.70; p<0.002) as well as Mest mRNA expression among adipose depots (iWAT vs eWAT Mest; R = 0.59; P<0.02) within each mouse which is consistent with previous studies [10, 16]. Analyses of subgroups of WT mice within the lowest (n = 6; WT-LM) and highest (n = 6; WT-HM) tertiles for eWAT Mest mRNA (Fig 2D) showed significant differences in BWT and adiposity between groups (Fig 2E and 2F). However, no differences were observed between WT-LM and MestpKO mice (Fig 2E and 2F). These data suggest that the low level of MEST in adipose tissue of WT-LM mice does not significantly contribute to additional ATE beyond that observed for MestpKO mice. Thus, increased ATE only becomes apparent in mice that show high interindividual WAT Mest expression.

thumbnail
Download:
Fig 2. Dietary obesity in mice with inactivated Mest.

(A) Longitudinal measurement of bodyweight (BWT) in 17 wildtype (WT) mice and 10 mice with inactivation of Mest on the paternal allele (pKO). Mice were fed high fat diet (HFD) from 8 to 16 weeks of age as indicated by the arrow along the X-axis. (B) Longitudinal measurements show the ratio of fat mass (FM) and lean mass (LM) measured by NMR, indicated as adiposity index (FM/LM), in 17 WT and 10 pKO mice fed a HFD from 8 to 16 weeks as shown by the arrow along the X-axis. (C) Data shows the cumulative change of fat mass (Δ Fat Mass) and fat-free mass (Δ FFM; inset graph) of 17 WT and 10 MestpKO (pKO) mice after initiation of a HFD at 8 weeks of age until 16 weeks of age as indicated on the X-axis. (D) Data represents tertiles of mice from the 17 WT mice in the study with the lowest (WT-LM; n = 6) and highest (WT-HM; n = 6) epididymal white adipose tissue (eWAT) Mest expression. Gene expression was measured by TaqMan QRT-PCR and is represented as arbitrary units (AU) normalized to cyclophilin b (Ppib). (E) Longitudinal analyses of BWT and (F) adiposity index in mice within WT-LM and WT-HM tertiles for eWAT Mest and pKO mice are shown. Data in all figures are presented as the mean ± SEM. Significance at each time point of the longitudinal phenotypic analyses between WT and pKO (A- C) was determined by 2-way ANOVA using the Holm-Sidak multiple comparisons test. Time points annotated with 1, 2, 3 or 4 asterisks indicate significant differences of P≤0.05, P≤0.01, P≤0.001 and P≤0.0001 respectively. Significance in eWAT Mest RNA expression between the WT-LM and WT-HM groups (D) was measured by a two-tailed unpaired parametric t-test and is indicated on the bar graph. Longitudinal data for WT-LM, WT-HM and pKO (E and F) was performed using 2-way ANOVA using Tukey’s multiple comparisons test. Annotation with ‘a’ and ‘b’ indicates significant differences between WT-HM vs pKO and WT-HM vs WT-LM mice respectively.

https://doi.org/10.1371/journal.pone.0179879.g002

Adipose tissue inactivation of Mest

Mice with a floxed paternal allele for Mest (MestpFL; Fig 1A) were crossed with Adipoq-cre transgenic mice to generate animals with an Adipoq-cre mediated inactivation of the paternal allele (MestApKO) of Mest. Analyses of WAT Mest mRNA in cohorts of 5–17 age-matched male mice fed an obesogenic diet for 16 weeks showed a >98% reduction in both iWAT and eWAT Mest mRNA expression (Fig 3A) in MestApKO mice compared with the 3 control groups (i.e. WT, WT-cre and MestpFL; Fig 3A) and supports previous studies showing that Mest is expressed in the mature adipocyte fraction of adipocytes [10, 20]. In addition, the presence of loxP sites in the 5’ and 3’ introns surrounding Mest exon 3 of MestpFL did not adversely affect Mest expression. Longitudinal analyses of bodyweight and body composition in mice fed a HFD shows significantly reduced bodyweight gain and fat mass accumulation in the MestApKO mice (Fig 3B and 3C), but no changes in fat-free mass (Fig 3D), compared to the 3 control groups. Reduced bodyweight and adiposity in MestApKO mice is consistent with the phenotypes observed for the MestpKO mice (Fig 2). Both genetic models suggest that MEST facilitates ATE in an obesogenic environment. An additional cohort of mice with Fabp4-cre mediated inactivation of Mest show similar phenotypic profiles compared to the MestApKO mice (S1 Fig).

thumbnail
Download:
Fig 3. Dietary obesity in mice with Adipoq-cre mediated inactivation of Mest.

(A) Mest mRNA expression in inguinal (iWAT) and epididymal (eWAT) white adipose tissue of wildtype (WT; n = 9), WT.Adipoq-cre (WT-cre; n = 5), paternal floxed Mest (pFL; n = 11) and pFL.Adipoq-cre (ApKO; n = 17) mice after being fed a HFD from 8–24 weeks of age. Mest mRNA expression measured by TaqMan QRT-PCR is represented as the mean ± SEM of arbitrary units (AU) normalized to TATA-box binding protein (Tbp). Significance in Mest RNA expression between groups was determined via one-way ANOVA using Tukey’s multiple comparisons test. (B) Data shows the longitudinal measurements of bodyweight (BWT) for WT (n = 9), WT-cre (n = 5), pFL (n = 11) and ApKO (n = 17) mice fed a HFD from 8 to 24 weeks of age as indicated by the arrow along the X-axis. (C) Longitudinal measurements of fat mass (g) and (D) fat-free mass (g) measured by DEXA at the times indicated on the X-axis are shown for WT (n = 9), WT-cre (n = 5), pFL (n = 11) and ApKO (n = 17) mice fed a HFD from 8 to 24 weeks of age as indicated by the arrow along the X-axis. (B-D) All data in the longitudinal studies are presented as the mean ± SEM. Significance at each time point of the longitudinal phenotypic analyses was determined by 2-way ANOVA and Tukey’s multiple comparisons test. Time points annotated with ‘a’ and ‘b’ indicates significant differences between ‘ApKO vs pFL’ and ‘ApKO vs WT’.

https://doi.org/10.1371/journal.pone.0179879.g003

Metabolic parameters and adipocyte morphology

To prevent aberrant phenotypic measurements due to stress from over-manipulation of the animals, two additional cohorts of MestpKO mice and littermate WT controls were used to examine diabetic and metabolic parameters. A cohort used to measure glucose (GTT) and insulin tolerance (ITT) showed no significant differences in bodyweight (WT, N = 8, 22.51 ± 0.26 g vs MestpKO, N = 7, 22.13 ± 0.30 g; p = 0.35) or glucose tolerance (Fig 4A) between chow-fed WT and MestpKO mice at 8 weeks of age. However, after feeding mice a HFD from 8 to 16 weeks of age, MestpKO mice showed reduced bodyweight (WT, 38.46 ± 0.96 grams vs MestpKO, 33.71 ± 1.45 grams; p<0.02) and improved glucose (Fig 4B) and insulin (Fig 4C) tolerance compared to WT littermate controls.

thumbnail
Download:
Fig 4. Diabetic and metabolic measurements of mice with inactivated Mest.

(A) Data shows glucose tolerance test (GTT) of WT (n = 8) and MestpKO (pKO) mice (n = 7) fed a chow diet at 8 weeks of age. (B) GTT and (C) insulin tolerance test (ITT) of WT (n = 8) and pKO (n = 7) at 16 weeks of age after feeding mice a high fat diet (HFD) for 8 weeks. (D) Bodyweight (BWT), (E) adiposity index (fat mass/lean mass; FM/LM) and (F) food intake (FI; kJ/day normalized to fat-free mass (FFM) are presented for an additional cohort of WT (n = 8) and pKO (n = 8) mice fed a HFD from 8 to 16 weeks of age that were subjected to indirect calorimetric analyses. Body composition measurements were performed via DEXA. Indirect calorimetric measurements of (G) respiratory quotient (RQ), (H) energy expenditure (EE), (I) wheel running distance (WhDst) and (J) wheel speed (WhSpd) were performed on mice for 1 week after being fed a HFD for 8 weeks. All data is presented as the mean ± SEM. Significance between groups was determined using two-tailed unpaired parametric t-tests and 1 or 2 asterisks indicate significant P-values of ≤0.05 and ≤0.01 respectively.

https://doi.org/10.1371/journal.pone.0179879.g004

An independent cohort of HFD-fed WT (n = 8) and MestpKO (n = 8) mice that were subjected to indirect calorimetry showed similar differences in both bodyweight and adiposity (Fig 4D and 4E) as previously observed. Surprisingly, caloric intake normalized to fat-free mass (kJ/d/g FFM) measured in mice fed HFD at 8 and 16 weeks of age was similar between WT and MestpKO mice (Fig 4F) suggesting that differences in food consumption is not a causative factor for the divergence in adiposity between genotypes. Respiratory quotient (RQ) measured in 16 week old mice after feeding a HFD for 8 weeks were identical between genotypes (Fig 4G) and RQ values levels were consistently below 0.8 indicating that fat, as expected due to feeding the mice HFD, is the primary fuel source for both genotypes. Although no significant differences in energy expenditure (EE; kcal/hr/kg FFM) were noted between genotypes (Fig 4H) at 16 weeks of age, MestpKO mice did show a ~4–5% elevation in 24 hour EE compared to WT mice. Analyses of physical activity based on wheel running at 16 weeks of age shows that MestpKO mice consistently ran ~15% further (Fig 4I; p≤0.05) and faster (Fig 4J; p≤0.01) than WT mice at night which could at least partially explain the slight increase in EE observed for MestpKO mice.

Adipocyte morphology for both eWAT and iWAT, determined for the cohort of mice used in the HFD study described in Fig 2 shows that WT mice with high WAT Mest expression (WT-HM) have significantly larger adipocytes in eWAT (Fig 5A and 5B) compared to MestpKO (p<0.005) or WT mice with low WAT Mest expression (WT-LM; p<0.001). Although the size of adipocytes in iWAT (Fig 5C) was not different between genotypes, the general trend of increased adipocyte hypertrophy in mice within the HM group was evident in both WAT depots. These results are consistent with previous studies using B6 mice fed a HFD that showed a positive correlation between adiposity and adipocyte size with WAT Mest mRNA and protein [16].

thumbnail
Download:
Fig 5. Adipocyte size determination in mice with inactivated Mest.

(A) A representative image shows variation in the size of adipocytes in eWAT of WT mice with high (WT-HM; n = 3) and low (WT-LM; n = 3) epididymal adipose tissue (eWAT) Mest expression and MestpKO (pKO) mice (n = 3). (B and C) Box and whisker graphs show the median and range of adipocyte sizes determined morphometrically for WT (n = 17), pKO (n = 10), WT-LM (n = 6) and WT-HM (n = 6) mice for both eWAT and inguinal adipose tissue (iWAT). Significance between groups was determined using two-tailed unpaired parametric t-tests. Datasets annotated with the same letter indicate no significant differences between groups.

https://doi.org/10.1371/journal.pone.0179879.g005

Gene expression analyses

Gene expression markers for macrophage infiltration/inflammation were used to determine whether improved glucose tolerance in HFD-fed MestpKO mice (Fig 4B) is concomitant with reduced inflammatory state of WAT. Gene expression analyses of adipose tissue of the WT, MestpKO, WT-LM and WT-HM mice used in the HFD study described in Fig 2 showed reduced expression of Ccl2 (Mcp-1), Hmox1, Itgam and Itgax in eWAT of MestpKO compared to the WT and WT-HM mice (Fig 6A, 6B, 6C and 6D). Although differences in the expression of these gene markers between groups were not as prominent in iWAT compared with eWAT, they were consistent with that observed for eWAT except for Itgax which showed no differences between groups. The absence of differences in gene expression between the WT-LM and MestpKO mice suggest that changes in gene expression in MestpKO mice are associated with the reduction of ATE and suppression of inflammation. Furthermore, the analyses of hepatic gene expression in WT vs MestpKO mice show no differences in the expression of Fas (WT; 10.09 ± 0.75 vs MestpKO; 10.47 ± 1.53 AU/Tbp; p = 0.83) and Scd1 (WT; 11.55 ± 0.70 vs MestpKO; 11.93 ± 1.22 AU/Tbp; p = 0.79), genes involved in hepatic de novo lipogenesis that have been shown to be positively associated with hepatic steatosis [49–52]. These data indicate that reduced ATE in MestpKO mice does not result in the development of a lipodystrophic state characterized by excessive hepatic accumulation of lipid.

thumbnail
Download:
Fig 6. Inflammatory genes in WAT of mice with inactivated Mest.

A, B, C and D show expression of gene markers for inflammation and macrophage infiltration in WAT of WT and MestpKO (pKO) mice. Gene expression was determined via TaqMan qRT-PCR in total RNA from eWAT and iWAT of wildtype (WT; n = 17), mice with a paternal inactivation of Mest (pKO; n = 10) and subgroups of WT mice with low (LM; n = 6) and high (HM; n = 6) WAT Mest expression after being fed a HFD from 8–16 weeks of age. Gene expression is represented as arbitrary units (AU) normalized to Tbp and presented as the mean ± SEM. Statistical analysis between genotypes within each WAT depot was performed using two-tailed unpaired parametric t-tests and datasets annotated with the same letter indicate no significant differences between groups.

https://doi.org/10.1371/journal.pone.0179879.g006

Activation of both canonical and non-canonical Wnt signaling has been shown to inhibit adipogenesis, mediate adipose tissue development and expansion and promote adipose tissue inflammation in obesogenic conditions [53–55]. Because previous studies have shown that adipose tissue Mest mRNA expression is positively associated with a subset of genes that include Wnt signaling inhibitors (i.e. Sfrp5 and Nkd1), in addition to the Tgfb-pathway mediator Bmp3 and the serine protease inhibitor Serpine1 [10, 13, 16], an analyses of this subset of genes in eWAT and iWAT of WT and MestpKO mice from the HFD study described in Fig 2 was performed to determine effects of Mest inactivation on their expression. Surprisingly, inactivation of Mest did not significantly alter WAT expression of Sfrp5, Bmp3, Nkd1 and Serpine1 (Fig 7B, 7C, 7D and 7E) with levels of expression comparable to WT-LM mice. However, consistent with previous studies [10, 13, 16], WT-HM mice did show elevated levels of Sfrp5, Bmp3, Nkd1 and Serpine1 expression compared with WT-LM mice for both WAT depots (Fig 7B, 7C, 7D and 7E). Additional regression analyses of gene expression in WAT of the 17 WT mice used in the HFD-study in Fig 2 showed significant correlations between Mest vs Sfrp5 (p = 0.00067), Bmp3 (p = 0.013) and Nkd1 (p = 0.031) in eWAT; and, between Mest vs Sfrp5 (p = 0.000025), Bmp3 (p = 0.013), Nkd1 (p = 0.0081) and Serpine1 (p = 0.0052) in iWAT. No differences in Pparg expression were observed between groups (Fig 7F) and Pparg mRNA in WAT was not associated with WAT Mest as shown in previous studies [7].

thumbnail
Download:
Fig 7. WAT gene expression in mice with inactivated Mest.

(A) Data shows expression of Mest, (B) Sfrp5, (C) Bmp3, (D) Nkd1, (E) Serpine1, and (F) Pparg in epididymal (eWAT) and inguinal (iWAT) white adipose tissue of wildtype (WT; n = 17) mice with a paternal inactivation of Mest (pKO; n = 10) and subgroups of WT mice with low (LM; n = 6) and high (HM; n = 6) WAT Mest expression after being fed a HFD from 8–16 weeks of age. Gene expression was determined via TaqMan qRT-PCR in total RNA from eWAT and iWAT and represented as arbitrary units (AU) normalized to cyclophilin b (Ppib). Gene expression is presented as the mean ± SEM and significance between groups was determined using two-tailed unpaired parametric t-tests. Datasets annotated with the same letter indicate no significant differences between groups.

https://doi.org/10.1371/journal.pone.0179879.g007

A global analysis of gene expression via ABI SOLiD SAGE sequencing was used to identify genes and genetic pathways that are dysregulated in adipose tissue of mice with a targeted inactivation of Mest (Fig 8). Gene profiles for eWAT were analyzed for 6 WT and 5 MestpKO mice selected from the cohort used in the HFD study in Fig 2. Adiposity indices (FM/LM ratio) of the WT mice were significantly higher than MestpKO mice (WT, 0.724 ± 0.030; MestpKO, 0.571 ± 0.019; p = 0.003) after the 8 weeks of HFD. A Venn diagram (Fig 8A) shows surprisingly few genes from the 15,453 gene targets detected in eWAT to have significantly higher (n = 27) or lower expression (n = 9) in WT vs MestpKO mice when FDR-adjusted to P<0.1 (S1 Table). Mest, as expected, was significantly reduced >15-fold in eWAT of MestpKO mice and TaqMan qRT-PCR validation showed undetectable (reduced >100-fold) levels of Mest in eWAT and iWAT of MestpKO mice (Table 1). Analyses of 14 additional selected genes with RNA from the individual eWAT samples used for ABI SOLiD SAGE sequencing via qRT-PCR showed significant and consistent differences between WT and MestpKO mice in the expression of 10 genes whereas 2 genes (Negr1, Mrap) showed no significant differences between groups and 2 genes (Plagl2, Tph2) could not be detected (Table 1). Additional analyses of eWAT RNA from the entire cohort of 17-WT and 10- MestpKO mice also showed comparable patterns of expression for the 10 differentially-expressed genes with the global and sample validation studies (Table 1). Importantly, 7 of the 10 genes showed similar expression patterns for both iWAT and eWAT whereas the expression of 3 genes (Gsta3, Ucp2 and Ces1f) only showed differences in eWAT.

thumbnail
Download:
Fig 8. Global analyses of gene expression in eWAT of mice with global inactivation of Mest.

(A) A Venn diagram represents a summary of ABI SoLID SAGE analyses of differentially expressed genes in eWAT of 6-wildtype (WT) and 5- MestpKO (pKO) mice fed a high fat diet from 8 to 16 weeks of age. Differentially expressed genes have a false discovery rate (FDR) adjusted P-value ≤ 0.1 and at least one genotype with ≥ 50 sequenced tags per gene. (B) The bar graph represents pathway analyses of 695 genes differentially expressed in eWAT of WT versus MestpKO mice that have non-adjusted P-values of ≤ 0.05 and at least one genotype with ≥ 50 sequenced tags per gene (S2 Table).

https://doi.org/10.1371/journal.pone.0179879.g008

thumbnail
Download:
Table 1. Validation of differentially-expressed genes in eWAT of WT and pKO mice.

https://doi.org/10.1371/journal.pone.0179879.t001

Ontology and enrichment analyses of the 27 genes with reduced expression in eWAT of MestpKO mice showed associations with several biological processes including cation transport (Tfr2, Atp6v0a1, Atp6v0d2, Slc5a7, Ccdc109b and Trdn; P<10−4), regulation of growth of symbiont in host (Lbp, Irf8; P<10−3), myeloid leukocyte activation (Lbp, Pirb, Ubd; P<10−3) and acute phase response (Lbp, Hp; P<10−3); however, none of the associations were significant after FDR correction. Genes more highly expressed in eWAT of MestpKO showed modest association with mycotoxin/aflatoxin catabolism and metabolism (Gsta3; P<10−3) and monoterpenoid metabolism (Cyp2e1; P<10−3). Further enrichment analyses performed on non-FDR-adjusted gene sets with a P-value cutoff of ≤ 0.05 and a minimum of 50 sequence tags for each mRNA in at least one of the groups identified 695 gene targets that were differentially expressed in eWAT of WT vs MestpKO mice (S2 Table). The 395 genes with reduced expression in eWAT of MestpKO mice showed highly significant associations with immune system processes (Padjusted <10−10) including defense, immune, inflammatory and stress responses whereas genes with increased expression in eWAT of MestpKO mice (n = 301) showed enrichment for single-organism metabolic processes (Padjusted<10−3) including oxidation-reduction, organic acid metabolism; and, fatty acid, acyl-CoA, thioester and monocarboxylic acid metabolism (Fig 8B). An examination of the expression of the mature mouse macrophage gene marker F4/80 (Emr1; Adgre1), and gene markers that delineate classically (M1) versus alternatively (M2) macrophage subtypes [56] only showed significantly elevated expression for the M1 macrophage marker Gpr18 (p = 0.04) and M2 macrophage marker Egr2 (p = 0.02) in eWAT of WT mice. No differences in expression between genotypes were observed for F4/80, Cd38, Fpr2, Cd163, Cd68 and Myc.

Adipogenic differentiation of Ear-derived mesenchymal stem cells

In vivo inactivation of Mest both globally and in adipocytes was shown to reduce adiposity (Figs 2 and 3); therefore, studies were initiated to determine whether similar effects of Mest inactivation can be observed in an adipogenic population of primary ear-derived mesenchymal progenitor cells (EMSC) from mice [57]. Results showed that EMSC from MestgKO mice were comparable in their capacity for adipogenic differentiation and accumulation of lipids compared to EMSC from WT mice as indicated by the panels showing oil red O (ORO) staining of lipids and crystal violet (CV) staining of cell nuclei (Fig 9A); and, in longitudinal profiles of lipogenesis measured by spectrophotometric determination of ORO in two independent experiments (Fig 9B and 9C). Although these results are somewhat contradictory to what is observed with in vivo studies, one possible explanation for the lack of effect of Mest inactivation in EMSC adipogenesis could be that cellular access to abundant nutrients and robust expression of lipid biosynthetic glycerol- and acyl-glycerol phosphate acyl transferases (GPATs and AGPATs) simply overwhelms the contribution MEST might have in facilitating lipid accumulation. By using an approach similar to one that used siRNA knockdown of GPAM in HEK293 cells to confirm GPAT-function for AGPAT6 [58], now renamed GPAT4, it was hypothesized that attenuation of GPAT/AGPAT function in EMSC might allow the contribution of MEST in lipid accumulation in EMSC undergoing adipogenesis to emerge. To test this possibility, EMSC were transduced with a lentiviral (LV) construct expressing shRNA against Gpat4, a glycerol-3-phosphate O-acyltransferase that catalyzes the acylation of glycerol-3-phosphate in the first and rate limiting step of de novo triacylglycerol and glycerophospholipid synthesis. Gpat4 was selected because, like Mest, it is localized within the endoplasmic reticulum (ER) [59] and is expressed during adipogenic differentiation of EMSC derived from both WT and MestgKO mice (Fig 9D and 9E). Expression of Gpat4 in EMSC from WT mice transduced with LV shRNA against Gpat4 (GP4KD) was reduced ~65–70% 5 days after initiation of adipogenic differentiation (Fig 9D). The expression of Agpat2 and Gpat3, which have 42% and 67% coding sequence identity with Gpat4 and are highly expressed in EMSC during adipogenic differentiation, are unaffected in the GP4KD EMSC (Fig 9D). Interestingly, Mest expression was modestly increased ~30% in GP4KD EMSC which suggests that its activation is a possible compensatory response to the attenuation of GPAT4 function. An independent longitudinal study using EMSC from WT and MestgKO mice in the absence or presence of GP4KD shows comparable temporal patterns of Gpat4 expression during 7 days of adipogenic differentiation among genotypes which was significantly attenuated by the GP4KD (Fig 9E). Mest expression in WT GP4KD EMSC was initially lower than WT EMSC during the first 3 days after adipogenic differentiation was initiated (i.e. D0-D3), but was higher than WT EMSC by day 5 post-differentiation (Fig 9F) which is consistent with previous results (Fig 9D). While GP4KD transduced WT and MestgKO EMSC showed highly attenuated lipogenesis (Fig 9G) compared to non-transduced cells (Fig 9A), GP4KD was significantly more effective in mitigating lipogenesis in MestgKO EMSC compared with WT EMSC as observed in the ORO/CV stained image (Fig 9G) and in the spectrophotometric measurements of ORO stained lipids in two independent longitudinal studies (Fig 9H and 9I). These data suggest that intact MEST function in WT EMSC diminishes GP4KD-mediated reductions of lipogenesis and supports a role for MEST in facilitating lipid accumulation.

thumbnail
Download:
Fig 9. In vitro analysis of adipogenesis and effects of Gpat4 -knockdown on ear-derived mesenchymal progenitor cells from wildtype and Mest KO mice.

(A) Oil red O (ORO) staining of lipid is shown in representative 10X (gray-scale) microscopic images of ear-derived mesenchymal progenitor cells (EMSC) from WT and homozygous Mest knockout (KO) mice prior to (D0) and after 5 days (D5) of adipogenic differentiation. (B) Graph represents spectrophotometric measurements of eluted ORO (ug) during 7 days of adipogenic differentiation using 3–4 replicate cultures of EMSC from WT and Mest KO mice for each time point on the X-axis. (C) Data shows an additional independent experiment using 3–4 replicate cultures of EMSC from WT and Mest KO mice at each time point during adipogenic differentiation that were stained with ORO and counterstained with crystal violet (CV) to normalize for cell number. (D) Figure shows mRNA expression of Gpat4, Agpat2, Gpat3 and Mest measured by qRT-PCR in WT EMSC in the absence (Control; n = 3) or presence of lentiviral shRNA knockdown of Gpat4 (GP4KD; n = 3) at post-adipogenic differentiation day 5. Gene expression data is presented as arbitrary units normalized to Tbp (AU/Tbp). Significance in gene expression between control and GP4KD cells was determined using two-tailed unpaired parametric t-tests and p-values between groups are indicated. (E) and (F) show Gpat4 and Mest mRNA expression in duplicate samples for WT and Mest KO EMSC in the absence or presence of GP4KD during adipogenic differentiation from D0 to D7. (G) ORO staining of lipid is shown in representative 10X (gray-scale) microscopic images of WT and Mest KO EMSC in the presence of GP4KD prior to (D0) and after 5 days (D5) of adipogenic differentiation. (H) Spectrophotometric profiles of eluted ORO during 7 days of adipogenic differentiation are shown for 3–4 replicates of WT and Mest KO EMSC after GP4KD are shown for each time point on the X-axis. (I) Data shows an additional independent experiment using 3–4 replicate cultures of EMSC from WT and Mest KO mice after GP4KD at each time point during adipogenic differentiation that were stained with ORO and counterstained with CV to normalize for cell number. Significance at each time point of adipogenic differentiation (B, C, H and I) was determined by 2-way ANOVA and Sidak’s multiple comparisons test. Datasets with 2, 3 or 4 asterisks indicate p-values of <0.01, <0.001 and <0.0001 respectively.

https://doi.org/10.1371/journal.pone.0179879.g009

Discussion

Since adipose tissue Mest was found to be positively associated with variable development of diet-induced obesity within a genetically homogeneous population of mice [10], a number of studies by our laboratory and others have utilized Mest as a sensitive biological indicator for adipocyte hypertrophy and fat expansion [7, 14, 16, 21, 60]. The initial characterization of mice with a targeted inactivation of Mest on a mixed genetic background (Mesttm1Lef) did not describe adiposity-related phenotypes; however, these mice were smaller than control animals, had high rates of early post-natal lethality and showed abnormal maternal behavior [43]. Subsequent analyses of a subset of 9-month old Mesttm1Lef mice on a mixed B6/129 background showed modestly reduced bodyweights and fat pad weights suggesting a role for MEST in the storage of lipid in adipocytes [16]. To avoid problems associated with abnormal maternal behavior and post-natal lethality in Mest-deficient mice, which would confound the interpretation of MEST function in diet-induced obesity and adipose tissue expansion (ATE), we generated an isogenic (C57BL/6J) mouse model with loxP sites flanking the 3rd exon of Mest to selectively inactivate Mest in a tissue-specific manner. Surprisingly, the creation of mice with Ella-cre-mediated global inactivation of Mest using our targeted model, unlike the Mesttm1Lef mice [43], did not result in increased risk of early post-natal lethality, reduced post-natal longitudinal growth, or abnormal maternal behavioral phenotypes. The reasons for differences between our targeted Mest mouse model and Mesttm1Lef are not well understood but could be due to differences in the genetic background of the mice, the gene targeting construct, or mutation(s) in the host ES cell used for targeting [61]. Recently it was reported that backcrossing targeted Mesttm1Lef mice 5 generations onto a129/SVJ background also eliminated the early postnatal lethality and maternal behavioral phenotypes of mice with a paternal inactivation of Mest; however, the explanation why this occurred was not clearly defined [62].

A microRNA (miR-335) suggested to have a role in the regulation of lipid metabolism, adipogenesis, adipose tissue inflammation and chondrogenesis [47, 48, 63] is located within the 2nd intron of Mest TV2 (Fig 1D) and only ~595 bp upstream (5’) from the loxP/NEO cassette used to generate the targeted Mest allele. The regulation of miR-335 is complex with some studies suggesting that it is a paternally expressed imprinted microRNA that is co-regulated with Mest whereas others suggest that it can be regulated via its own promoter [48, 64]. Since it is plausible that perturbed miR-335 function could modify ATE in our mouse model, it was necessary to determine whether miR-335 is dysregulated in mice with targeted Mest. Analyses of miRNA-335-5p expression in iWAT of 6–7 day old mice, at a time when fat accretion is rapid and Mest is highly expressed [16], showed comparable levels of miR-335 for all genotypes (Fig 1E) with no evidence for dysregulation of miR-335 in mice with inactivated Mest. Normal miR-335 expression in mice with a targeted allele of Mest suggests that phenotypic differences primarily result from loss of MEST function.

HFD-fed mice with inactivation of Mest on the paternal allele (MestpKO) showed significantly reduced bodyweight (Fig 2A), adiposity (Fig 2B and 2C), adipocyte hypertrophy (Fig 4) and improved glucose and insulin tolerance (Fig 4B and 4C); but, relatively few differences in metabolic parameters measured by indirect calorimetry (Fig 4G, 4H, 4I and 4J) compared to WT littermate controls. Although a reduction in bodyweight of just a little over 4 grams between male MestpKO and WT mice after being fed a HFD for 8 weeks appears to be modest, this would be equivalent to a 177 vs 200 pound individual with ~75% (~17.3 lbs) of the additional bodyweight being fat mass. Additional studies using MestpFL mice with either Adipoq- or Fabp4-cre mediated inactivation of the paternal Mest allele primarily in adipocytes (Fig 3; S1 Fig) showed similar reductions in both bodyweight and adiposity compared to their respective littermate controls suggesting that inactivation of Mest in adipocytes is predominantly responsible for the observed differences in adiposity related phenotypes between genotypes.

A predicted complication in assessing phenotypic differences between WT mice and mice with global or adipose tissue specific inactivation of Mest was the expected variability in the development of obesity within the WT cohort and its positive association with WAT MEST [7, 10, 16]. This was in fact the case and was exemplified by the analyses of tertiles (n = 6) of WT mice with the lowest (WT-LM) and highest (WT-HM) eWAT Mest mRNA expression (Fig 2D and 2E). Our analyses showed that differences in bodyweight and adiposity were more pronounced when comparing MestpKO with WT-HM mice and were consistent with previous studies of interindividual variation of Mest in the absence of genetic heterogeneity. When tertiles for male WT mice based on eWAT Mest expression are extrapolated to human body weight, WT-HM and WT-LM would weigh 215 vs183 pounds respectively. The lack of difference observed for bodyweight, adiposity, and adipocyte hypertrophy between WT-LM and MestpKO mice fed a HFD suggests that ‘basal’ levels of ATE do not require MEST. Additionally, studies showing increased adipocyte hypertrophy in mice with transgenic overexpression of Mest [20] coupled with high interindividual variability in WAT Mest expression in a genetically homogeneous population of mice [10, 16, 65] supports the premise that MEST could be an ‘epigenetically’ regulated rheostat for the control of ATE beyond defined basal levels established by the genetic background.

A concern with the ablation of Mest in a murine mouse model was that it could reduce the capacity for WAT to expand in an obesogenic environment leading to adipose dysfunction, ectopic accumulation of hepatic and intramuscular lipid, and impaired insulin sensitivity similar to that observed in lipodystrophy [66, 67]. However, MestpKO mice fed a HFD for 8 weeks showed markedly improved glucose homeostasis compared with WT controls (Fig 4B and 4C) which suggest that the suppression of ATE in MestpKO mice does not adversely affect metabolic health of WAT. These observations are supported by reduced WAT expression of markers for inflammation, hypoxia and macrophage infiltration in MestpKO and WT-LM mice compared to WT-HM mice (Fig 6) and lack of differences in hepatic expression of genes shown to be associated with the development of hepatic steatosis [49–52]. Data suggests that improved glucose tolerance is at least partially caused by reduced ATE in mice with inactivated or low WAT Mest expression. Improved glucose metabolism in association with reduced adipocyte lipid accumulation in mice with deficient Mest, caused by reduced adipocyte lipid accumulation shows similarity to the maintenance of normal glucose metabolism by caloric restriction; or, by mechanisms that enhance energy expenditure such as physical activity or cold-activated thermogenesis [68–73].

Although WT mice accrued significantly more bodyweight and adiposity than MestpKO mice after being fed a HFD for 8 weeks (Fig 4D and 4E), there were no differences in caloric intake between genotypes when measured during the initial (wk 8) and final week (wk 16) of high fat feeding (Fig 4F). Since indirect calorimetric measurements showed a consistent but non-significant (~4–5%) increase in energy expenditure for MestpKO mice during the day and night (Fig 4H) as well as significantly increased nighttime activity (Fig 4I and 4J), it is possible that these small differences in energy expenditure during the 8-week longitudinal study could contribute to some of the phenotypic differences in bodyweight and adiposity between genotypes.

Genes (i.e. Sfrp5, Bmp3, Nkd1 and Serpine1) expressed in WAT previously identified as being positively correlated with WAT Mest mRNA and variable development of adiposity in a genetically homogeneous population of mice fed obesogenic diet [7, 10, 16] were not significantly effected in WAT of MestpKO mice (Fig 7B, 7C, 7D and 7E). However, consistent with previous studies, analyses of WAT gene expression in the WT mice used in the HFD study in Fig 2 showed significant positive associations between eWAT Mest vs Sfrp5, Bmp3 and Nkd1; and, between iWAT Mest vs Sfrp5, Bmp3, Nkd1 and Serpine1. Since these genes were expressed at similar levels in WAT of HFD-fed MestpKO and WT-LM mice (Fig 7A, 7B, 7C, 7D and 7E), both of which show comparable weight gain and adiposity (Fig 2E and 2F), this suggests that differences in adiposity rather than WAT MEST affects their expression.

RNA-Seq analyses performed with RNA from eWAT of WT and MestpKO mice to gain insight into gene pathways and mechanisms related to MEST function revealed relatively few differences in gene expression (~36 genes) between genotypes when corrected for FDR at a p-value of <0.1 (Fig 8A) which suggests that ablation of Mest has relatively modest effects on gene expression in adipose tissue. This is an exciting feature of the association of reduced MEST and ATE with improved glucose/insulin metabolism because, unlike many other anti-obesity therapies, it provides encouragement that targeting the MEST pathway to reduce ATE may have a minimal number of side effects. Pathway analyses of genes with reduced and increased expression in eWAT of MestpKO mice (Fig 8A) showed modest associations with immune system-based pathways and metabolism/catabolism of toxins, respectively. The use of a broader set of genes with less stringent criteria for significance (S2 Table) in the gene ontology enrichment analyses also showed genes with reduced expression in eWAT of HFD-fed MestpKO mice to be associated with immune system processes (Fig 8B), including inflammation, which is consistent with improved glucose tolerance and insulin sensitivity in these mice. Genes more highly expressed in eWAT of MestpKO were categorized within multiple metabolic processes including those associated with metabolism of acyl-CoA, fatty acids and lipids (Fig 8B) and included a subset of carboxylesterases (Ces1d, Ces1f), carnitine palmitoyltransferase 2 (Cpt2) and glycerol-3-phosphate acyltransferases (Gpat4, Gpat3; S2 Table). Since elevated Mest is associated with increased adiposity, the increased expression of lipid biosynthetic genes in the absence of MEST may reflect a compensatory response. GPAT4, an integral membrane protein is important for the first step in catalyzing triglyceride synthesis and has been suggested to diffuse from the endoplasmic reticulum (ER) to lipid droplets via membrane bridges [74]. Since evidence suggests that MEST is localized within the ER [16, 20, 27], it’s plausible that interactions between MEST and GPAT4, or with other ER-localized GPATs or AGPATs, could facilitate triglyceride synthesis and storage in adipocytes. Studies are currently underway to delineate temporal patterns of MEST localization within the ER and its proximity to nascent lipid droplet formation.

Catalytic promiscuity and moonlighting are common among α/β-hydrolase fold proteins thus making it difficult to associate a specific catalytic function for MEST based on sequence homology [75–77]. Although the precise catalytic mechanism for MEST has not been defined, evidence showing a role for MEST in augmenting ATE and lipid accumulation in adipocytes [7, 16, 20] coupled with its intracellular localization within the ER [16, 20, 27] and the presence of a catalytic triad associated with proteases, lipases and acyltransferases within its peptide sequence [24, 26], all suggest that MEST acts to facilitate the accumulation of lipid in adipocytes.

The observation that mesenchymal progenitor cells (EMSC) derived from mice with a targeted inactivation of Mest (MestgKO) showed no difference in adipogenic potential and lipid accumulation compared to WT EMSC (Fig 9A, 9B and 9C) is contradictory to results showing increased lipid accumulation in 3T3-L1 adipocytes with transgenic overexpression of Mest [20]; and, underscores the complexity involved in understanding MEST function using in vitro models. However, in lentiviral shRNA knockdown of GPAT4, a gene whose inactivation in mice causes subdermal lipodystrophy and reduced diet-induced obesity [78], in both WT and MestgKO EMSC resulted in the emergence of differences in adipogenesis between the two genotypes with EMSC derived from MestgKO mice showing significantly reduced lipid accumulation compared to WT EMSC (Fig 9G, 9H and 9I). These data provide strong evidence that MEST at physiological levels may augment lipid accumulation and storage during adipogenic differentiation by its own endogenous acyltransferase activity, interact with or stabilize proteins associated with fatty acid uptake or lipid droplet formation, or reduce adipogenesis-suppressing intracellular levels of EET [35–37] via endogenous epoxide hydrolase activity. Proteomic and lipodomic studies are needed to further delineate the precise catalytic mechanisms associated with MEST and its role in mediating ATE and glucose homeostasis in WAT.

In summary, our data shows that reduced diet-induced ATE in MEST-deficient mice diminishes expression of markers of hypoxia and inflammation in WAT which leads to improved glucose tolerance and insulin sensitivity. Since minimal additional physiological effects are observed in mice with inactivation of Mest, an intervention that represses the function of MEST, or its associated pathway, could be a feasible strategy to mitigate obesity and the inception of T2D.

Methods

Gene targeting

A cre/loxP system was used to create mice with global and conditional inactivation of mesoderm specific transcript (Mest). DNA amplified from a C57BL/6J genomic BAC clone (RP24-211g11) was used to generate a targeting vector with loxP sites flanking exon 3 of Mest transcript variant/protein isoform 2 (NM_008590.2). A third loxP site flanking a NEO cassette (G418 resistance) 5’ of exon 3 was included as a selectable marker. Targeted C57BL/6J embryonic stem cells carrying the conditional floxed allele were introduced into C57BL/6J-Tyrc-2J host blastocysts and chimeric progeny crossed with C57BL/6J-Tyrc-2J mice to generate mice heterozygous for the targeted allele. The presence and correct orientation of the 3 loxP sites with respect to Mest exon 3 and the NEO cassette were confirmed via PCR. Generation of mice with global inactivation of Mest and with a floxed Mest exon 3 in the absence of the NEO cassette was achieved by crossing mice carrying the targeted allele to Ella-cre mice which has restricted expression of cre recombinase under the control of the adenoviral Ella promoter in oocytes and in preimplantation embryos [79]. Progeny that show positive PCR amplification patterns that correspond to a complete deletion of the floxed region and/or deletion of the NEO cassette were backcrossed to C57BL/6J mice to ensure germline transmission of the mutation and removal of the Ella-cre transgene.

Animals and study design

Since Mest is almost exclusively expressed from the paternally-derived allele in adult mice, experimental cohorts of mice with a paternal inactivation of Mest (MestpKO) were generated by crossing wildtype (WT) C57BL/6J female mice with male mice heterozygous for the inactivated (KO) Mest allele on the maternal allele (MestmKO). This cross yields equal ratios of WT and MestpKO mice. Complete knockout of Mest in tissues of MestpKO mice have been verified by both gene expression and Western blot analysis (Fig 1B and 1C). Longitudinal dietary obesity studies were performed using male WT and MestpKO mice because male C57BL/6J has greater susceptibility for the development of diet-induced obesity than females. Experimental cohorts of mice to study the conditional inactivation of Mest were generated via crosses between female mice that are hemizygous for either the Fabp4-cre (B6.Cg-Tg (Fabp4-cre)1Rev/J; JAX Stock# 005069) or Adipoq-cre (B6;FVB-Tg(Adipoq-cre)1Evdr/J; JAX Stock# 010803) transgenes with male mice containing either a maternal (MestmFL) or paternal (MestpFL) floxed allele for Mest. The resulting genotypes will include mice with Fabp4- or Adipoq-cre inactivation of the paternal allele for Mest (Mest FpKO or Mest ApKO respectively) and control groups consisting of WT, WT-cre (Fabp4- or Adipoq-cre) and MestpFL mice. Prior to use in generating experimental mice, the Adipoq-cre transgenic mice were crossed to C57BL/6J for several subsequent generations to eliminate potential genomic contribution from the FVB strain. Genomic analyses of the Adipoq-cre using a 1449 SNP marker panel (Taconic, Germantown, NY) confirms 99.79% C57BL/6J with the only residual genome of FVB located between ~83.5 and ~92.1 mb on mouse Chr 9, the putative genomic insertion site of the Adipoq-cre transgene [80].

The animals were maintained in a temperature-controlled room (23°C) with a 12-h light/12-hr dark cycle. For experiments performed at Pennington Biomedical Research Center, the mice were reared under conventional conditions and fed PicoLab Rodent Diet 20 (Lab Diet; 13 kcal% fat) after weaning. For experiments conducted at Maine Medical Center Research Institute Animal Facility, the mice were kept in a barrier facility and given 2018 Teklad Global 18% Protein Rodent Diet (Harlan; 18 kcal% fat) post-weaning. For dietary obesity studies mice were singly-housed at 7 weeks of age and then fed a high fat diet (HFD; D12331, Research Diets; 58 kcal% fat; 23.26 kJ/g) starting a 8 weeks of age for 8–16 weeks as indicated for each study cohort. The design used for the dietary obesity studies for each of the cohorts of mice are shown in S3 Table. Upon completion of the studies, all mice were sacrificed by anesthesia with isoflurane followed by cervical dislocation according to accepted guidelines and tissues were harvested for analyses. All animal experiments and methods were approved by the Institutional Animal Care and Use Committee at The Pennington Biomedical Research Center (Baton Rouge, LA) and The Maine Medical Center Research Institute (Scarborough, ME) in accordance with National Institutes of Health guidelines for care and use of laboratory animals.

Glucose and insulin tolerance tests

Glucose tolerance test (GTT) was performed in 7 week old male mice prior to initiation of high fat diet and repeated after 8 weeks on high fat diet. Mice were fasted overnight and administered 2 g/kg BW glucose intraperitoneally (IP). Blood glucose levels were determined using Accu-check Aviva plus system (Roche Diagnostics). Insulin tolerance test was conducted in mice fed high fat diet for 8 weeks. Mice were fasted for 6 hours and injected with human recombinant insulin (Humulin-R, Eli Lilly and Company) at a dose of 1.5 kg/BW IP.

Indirect calorimetry

The Promethion Metabolic Cage System (Sable Systems) was used for indirect calorimetry. The mice were acclimated to the system for 12-hrs followed by 72-hr data collection.

Determination of body composition

Nuclear magnetic resonance.

Body composition (body fat, lean mass and free fluid) was analyzed by Minispec NMR (Bruker) which allowed for non-invasive, serial body composition measurements in the mouse. The Minispec uses the contrasting hydrogen density and/or hydrogen spin properties from adipose tissue and muscle for estimating body composition. A quality control check of NMR parameters using a standard provided by the manufacturer was performed at the beginning of each day of testing.

Dual-energy X-ray absorptiometry.

Mice were scanned using the Lunar PIXImus densitometer (GE Medical Lunar; DEXA). Whole-body and femoral areal bone mineral density, and body composition excluding the head were determined in each mouse under isoflurane anesthesia (IsoFlo, Abbot Labs). The Piximus was calibrated at the beginning of each day of testing using a phantom according to the manufacturer’s instructions.

Histology and morphometrics of white adipose tissue

Inguinal (iWAT) and epididymal (eWAT) adipose tissue were fixed in Bouin’s solution (Sigma-Aldrich), and paraffin-embedded sections were stained with H & E. Adipocyte area and size distribution were analyzed using Image J software at specific parameters to measure area of each adipocyte based on size and exclusion limits.

Mest transcript variants

RNA was extracted from eWAT and iWAT of wild-type mice (Mest+/+) homogenized in TriReagent (Molecular Research Center, Inc.) and then purified using RNeasy Mini Kit and RNase-free DNAse (Qiagen). Isolated RNA was protected from RNAse contamination with SUPERase-In (Life Technologies). RNA quantity and quality was determined using Nanodrop 1000 spectrophotometer. Specific primers against the Mest transcript variants 1(TV1; forward: 5’-CCCTGTGATCCGCAATCCT-3’; reverse: 5’-ACTACTGTCTGCATTTGGGCTATG-3’), 2 (TV2; forward: 5’-GCGGCATGGGATAATGC-3’; reverse: 5’-CTACTTGGACCCACCACTCTCT-3’) and 3 (TV3; forward: 5’-GGGTAGAGAGAAAAAGTGTGGAA-3’; reverse: 5’-CCTCTAAGGAACAGCGACTTC-3’) were designed using Primer Express software v3.0.1 (Life Technologies) to yield amplicons ranging from 72 to 99 bp. White adipose tissue cDNA was synthesized using High-Capacity cDNA Reverse Transcription Kit (Life Technologies). Quantitative PCR was performed using 20 ng cDNA input and yield was compared between 25, 30 and 36 PCR cycles. PCR products were resolved using 3% GenePure LE agarose (ISC Bioexpress) in 1X TBE running buffer at 80 volts for 20 mins. Gel image was obtained using GelDoc-ItTS2 Imaging System (UVP).

Quantitative reverse transcription PCR

Expression of mRNA.

Quantitative reverse transcription-PCR was performed using total RNA with specific primers and probes (S3 Table) designed using Primer Express software v3.0.1 (Life Technologies) essentially as previously described [16] except that a BioRad CFX Real-Time System was also used for analyses. TaqMan probes (Biosearch Technologies) were used for gene quantification using TaqMan® RNA-to-CT 1-Step Kit (Life Technologies). Gene expression data were normalized to level of cyclophilin b (Ppib), or TATA box binding protein (Tbp). In addition, the total nanograms of input RNA/reaction was quantified using Qubit HS RNA Assay Kit (Life Technologies) and can be used to normalize gene expression by RNA input if necessary.

Expression of miRNA.

Total RNA including miRNAs was isolated from white adipose tissue using miRNeasy mini kit (Qiagen). cDNA synthesis was performed using the TaqMan® MicroRNA Reverse Transcription Kit and TaqMan miRNA specific primers (Life Technologies) for mmu-miR-335-5p, mmu-miR-335-3p and snoRNA202 (NCBI Accession #AF357327). The cDNA was amplified using the TaqMan Universal Mastermix II, no UNG and TaqMan Small RNA Assay (Life Technologies). Quantitive PCR was performed using the CFX384 Real Time PCR detection system (BioRad). Relative abundance of miR-335 was quantified using the 2-ΔΔCT method using snoRNA202 for normalization of expression.

Western blot analyses

Total tissue lysate from eWAT and iWAT were prepared in RIPA buffer containing 1% protease, phosphatase I and phosphatase II inhibitors (Sigma). Protein content was determined using Sigma BCA protein assay kit. Proteins were resolved on 10% SDS-PAGE gel and after separation electro-transferred to PVDF (Immobilon-P, EMD Millipore) or nitrocellulose (Hybond-ECL, GE Healthcare) membranes. Blots were incubated in antibodies against MEST (1:5000) and GAPDH (1:1000, ABCAM ab9484). Bands were visualized and quantified using the Odyssey imaging system (Li-Cor Bioscience).

In vitro cell culture

Experimental cohorts for in vitro experiments were generated by intercrossing Mest heterozygous mice to generate WT (+/+), MestpKO (+/KO) and MestgKO (KO/KO) mice. Ear mesenchymal stem cells (EMSCs) were isolated from WT and MestgKO mice as previously described [57]. Cells were cultured in 5% CO2 and maintained in DMEM/F-12 (Life Technologies) supplemented with 10% FBS (Life Technologies) supplemented with Primocin as an antibiotic (InVivoGen), and 10 ng/ml recombinant bFGF (PeproTech). To induce adipocyte differentiation, recombinant bFGF was removed and replaced with 10% FBS with 0.5 mM methylisobutylxanthine, 1 uM dexamethasone, 5 ug/ml insulin, and 5 uM troglitazone. On day 2, cells were fed 5 ug/ml insulin plus 5 uM troglitazone. On day 4 and every 2 days thereafter, cells were fed with 15% FBS. Lipid droplets were visualized using Oil Red O staining. Cells were washed with PBS followed by fixation with 10% neutral buffered formalin for 10 min. The cells were then washed once in dH2O and incubated in 60% isopropanol for 5 min. The isopropanol was removed and followed by an incubation in Oil Red O staining solution (0.35% Oil Red O in 60% isopropanol) for 10 min, washed once in 60% isopropanol and 3X for 10 min with dH2O. Oil Red O dye was eluted in 100% isopropanol for 15 minutes. The degree of adipogenic differentiation was quantified spectrophotometrically by measuring absorbance at 490 nm. A standard curve with known amounts of Oil Red O dye (ug/ml) was used to quantify lipid as total ug of Oil Red O eluted. After elution of Oil Red O dye, cells were then washed 1X with 100% isopropanol followed by dH2O and subsequently used for quantifying relative cell number by nuclear staining with crystal violet. Relative cell number was measured by staining cells with 0.05% crystal violet in deionized H2O for 5 minutes. The cells were then washed 3X for 10 min with dH2O then lysed in 1% SDS. Crystal violet in the 1% SDS lysate was measured at an absorbance of 560 nm a standard curve with known amounts of crystal violet (ug/ml) was used to quantify relative cell number and to normalize Oil Red O eluted from cells.

Gene knockdown

Five short-hairpin RNA (shRNA) constructs against Gpat4 (Agpat6) in lentiviral vector pLKO.1 were obtained from Sigma-Aldrich. For knockdown experiments, the construct chosen was TRCN0000099245. According to the manufacturer’s protocol, EMSC were transduced in maintenance medium in the presence of polybrene (Sigma-Aldrich). Transduction was performed at MOI = 2. After overnight incubation, virus-containing media was removed and standard culture media was added. Cells were allowed to expand for 48 hours and then selection was initiated using puromycin (Sigma-Aldrich) at 4 ug/ml. Puromycin-resistant cells were expanded until P6 and then seeded in 12-well plates at a density of 100,000 cells per well. Prior to lentiviral transduction, a titration was performed to determine the minimum concentration of puromycin required to cause complete cell death after 3–5 days. Cells were harvested for gene expression, Oil Red O and crystal violet staining.

SOLiD SAGE analyses

SAGE gene expression profiling was performed with next-generation sequencing using the Life Technologies 5500XL SOLiD system. RNA was isolated from tissues using TRI Reagent; quantified and quality was determined using an Agilent 2100 Bioanalyzer. RNA was transcribed into cDNA via priming at the poly A+ tail. Double-stranded cDNA was digested with NlaIII restriction enzyme and ligated to adaptors containing an EcoP15L restriction site. Digestion was performed with EcoP15L and ligation of "bar code" oligonucleotides that specifically label each sample, and subsequent PCR amplification yielded a library for sequencing where each gene was represented with a 3'-expression tag. The alignment of sequence tags back to a reference genome was performed using a modified version of the Applied Biosystems SOLiD™ SAGE™ Analysis Software v1.10 that was installed, modified to meet stringent mapping criteria, and extensively tested in-house. RNA isolated from eWAT of 6 independent wildtype control mice and 5 MestpKO mice were used for preparation of libraries and sequencing analyses. Raw count files were analyzed by the R/Bioconductor program DE-Seq31; significance and predictive analyses were performed using SAM (Significance Analysis of Microarrays; http://www-stat.stanford.edu/~tibs/SAM/index.html) and PAM (Prediction Analysis for Microarrays; http://statweb.stanford.edu/~tibs/PAM/index.html) respectively [81, 82]. P-values were adjusted for false discovery rate using the Benjamini-Hochberg method [83]. Pairwise analysis and hierarchical clustering of samples was performed using Bioconductor edgeR Version 3.2.3 and JMP Genomics respectively. Raw sequencing files from ABI SOLiD SAGE analyses have been deposited in NCBI’s Gene Expression Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/) with the accession number GSE96968.

Statistics

Statistical calculations were performed using GraphPad Prism software V.6 and Microsoft Excel 2010. Differences between 2 groups were calculated using two-tailed unpaired parametric t-test with confidence level at 95%. Significance among multiple groups was calculated with ordinary one-way ANOVA followed by Tukey’s multiple comparisons test with an alpha of 0.5 or by the Fisher’s LSD test as indicated. Significance at each time point of longitudinal phenotypic datasets was determined using 2-way ANOVA with Holm-Sidak multiple comparisons test. Data is presented as the mean ± SEM. P<0.05 was considered to be significant.

Ethics statement

The use of murine models for the studies presented in the submitted manuscript was approved by the Institutional Animal Care and Use Committees (IACUC) at the Pennington Biomedical Research Center and the Maine Medical Center Research Institutes.

Supporting information

S1 Fig. Dietary obesity in mice with Fabp4- cre mediated inactivation of Mest.

(A) Mest mRNA expression in inguinal (iWAT) and epididymal (eWAT) white adipose tissue of wildtype (WT; n = 8), WT.Fabp4-cre (WT-cre; n = 11), paternal floxed Mest (pFL; n = 6) and pFL.Fabp4-cre (FpKO; n = 12) mice after being fed a high fat diet (HFD) from 8 to 20 weeks of age. Mest mRNA expression measured by TaqMan QRT-PCR is represented as the mean ± SEM arbitrary units (AU) normalized to cyclophilin b (Ppib). Significance in Mest RNA expression between groups was determined via one-way ANOVA using Tukey’s multiple comparisons test. (B) Data shows the longitudinal measurements of bodyweight (BWT) for WT (n = 8), WT-cre (n = 11), pFL (n = 6) and FpKO (n = 12) mice fed a HFD from 8 to 20 weeks of age as indicated by the arrow along the X-axis. (C) Longitudinal measurements of adiposity index; (D) fat-free mass (g) and (E) fat mass (g) measured by NMR at the times indicated on the X-axis are shown for WT (n = 8), WT-cre (n = 11), pFL (n = 6) and FpKO (n = 12) mice fed a HFD from 8 to 20 weeks of age as indicated by the arrow along the X-axis. (B-E) All data in the longitudinal studies are presented as the mean ± SEM. Significance at each time point of the longitudinal phenotypic analyses was determined by 2-way ANOVA and Tukey’s multiple comparisons test. Time points annotated with ‘a’, ‘b’, ‘c’, and ‘d’ indicate significant differences between ‘FpKO vs pFL’; ‘FpKO vs WT’; ‘FpKO vs WT-cre’ and ‘FpKO vs all genotypes respectively. (F) Data shows morphometric analyses of adipocyte size in eWAT in WT (n = 8), WT-cre (n = 11), pFL (n = 6) and FpKO (n = 12) mice. Two-tailed unpaired parametric t-tests were used to determine significant differences in adipocyte size (F) between genotypes. Datasets annotated with the same letter indicate no significant differences between groups.

https://doi.org/10.1371/journal.pone.0179879.s001

(TIF)

S1 Table. Differential gene expression in eWAT: WT vs pKO; FDR padj ≤ 0.1.

https://doi.org/10.1371/journal.pone.0179879.s002

(DOCX)

S2 Table. Differential gene expression in eWAT; WT vs pKO; pvalue ≤ 0.05.

https://doi.org/10.1371/journal.pone.0179879.s003

(DOCX)

S3 Table. Murine cohorts and study design.

https://doi.org/10.1371/journal.pone.0179879.s004

(DOCX)

S4 Table. Primer and probe sets: qRT-PCR.

https://doi.org/10.1371/journal.pone.0179879.s005

(DOCX)

Acknowledgments

We thank Susan S. Newman, Richard Carmouche and J. Michael Salbaum at the Pennington Biomedical Research Center (PBRC) for providing valuable assistance in the design, performance and analyses of ABI SOLiD SAGE global gene expression studies, David Burke (PBRC) for assistance in the histopathological analyses of adipose tissue and David C. Higgins at the Maine Medical Center Research Institute (MMCRI) for providing valuable laboratory support.

Author Contributions

  1. Conceptualization: RAK LPK.
  2. Formal analysis: RAK RPA.
  3. Funding acquisition: RAK.
  4. Investigation: RAK RPA JM.
  5. Methodology: RLM JZ RAK RPA.
  6. Project administration: RAK.
  7. Visualization: RAK.
  8. Writing – original draft: RAK.
  9. Writing – review & editing: LPK RPA.

References

  1. 1. Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Theriault G, et al. The response to long-term overfeeding in identical twins. The New England journal of medicine. 1990;322(21):1477–82. pmid:2336074
  2. 2. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. The New England journal of medicine. 1990;322(21):1483–7. pmid:2336075
  3. 3. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206. pmid:25673413;
  4. 4. Bouchard C. Defining the genetic architecture of the predisposition to obesity: a challenging but not insurmountable task. The American journal of clinical nutrition. 2010;91(1):5–6. Epub 2009/11/27. pmid:19939981.
  5. 5. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature genetics. 2003;33 Suppl:245–54. pmid:12610534.
  6. 6. Li S, Zhao JH, Luan J, Luben RN, Rodwell SA, Khaw KT, et al. Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies. The American journal of clinical nutrition. 2010;91(1):184–90. Epub 2009/10/09. pmid:19812171.
  7. 7. Anunciado-Koza RP, Manuel J, Koza RA. Molecular correlates of fat mass expansion in C57BL/6J mice after short-term exposure to dietary fat. Annals of the New York Academy of Sciences. 2016;1363:50–8. pmid:26647164;
  8. 8. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab. 2002;282(4):E834–42. pmid:11882503.
  9. 9. Koza RA, Flurkey K, Graunke DM, Braun C, Pan HJ, Reifsnyder PC, et al. Contributions of dysregulated energy metabolism to type 2 diabetes development in NZO/H1Lt mice with polygenic obesity. Metabolism. 2004;53(6):799–808. pmid:15164332.
  10. 10. Koza RA, Nikonova L, Hogan J, Rim JS, Mendoza T, Faulk C, et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet. 2006;2(5):e81. pmid:16733553.
  11. 11. Yang Y, Smith DL Jr., Keating KD, Allison DB, Nagy TR. Variations in body weight, food intake and body composition after long-term high-fat diet feeding in C57BL/6J mice. Obesity (Silver Spring). 2014;22(10):2147–55. pmid:24942674;
  12. 12. de Fourmestraux V, Neubauer H, Poussin C, Farmer P, Falquet L, Burcelin R, et al. Transcript profiling suggests that differential metabolic adaptation of mice to a high fat diet is associated with changes in liver to muscle lipid fluxes. J Biol Chem. 2004;279(49):50743–53. pmid:15377667.
  13. 13. Kozak LP, Newman S, Chao PM, Mendoza T, Koza RA. The early nutritional environment of mice determines the capacity for adipose tissue expansion by modulating genes of caveolae structure. PLoS One. 2010;5(6):e11015. Epub 2010/06/25. pmid:20574519.
  14. 14. Chu DT, Malinowska E, Gawronska-Kozak B, Kozak LP. Expression of adipocyte biomarkers in a primary cell culture models reflects preweaning adipobiology. J Biol Chem. 2014;289(26):18478–88. pmid:24808178;
  15. 15. Kozak LP, Koza RA, Anunciado-Koza R, Mendoza T, Newman S. Inherent plasticity of brown adipogenesis in white fat of mice allows for recovery from effects of post-natal malnutrition. PLoS One. 2012;7(2):e30392. pmid:22383960;
  16. 16. Nikonova L, Koza RA, Mendoza T, Chao PM, Curley JP, Kozak LP. Mesoderm-specific transcript is associated with fat mass expansion in response to a positive energy balance. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2008;22(11):3925–37. Epub 2008/07/23. pmid:18644838.
  17. 17. Moraes RC, Blondet A, Birkenkamp-Demtroeder K, Tirard J, Orntoft TF, Gertler A, et al. Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology. 2003;144(11):4773–82. pmid:12960083.
  18. 18. Soukas A, Cohen P, Socci ND, Friedman JM. Leptin-specific patterns of gene expression in white adipose tissue. Genes & development. 2000;14(8):963–80. 0010783168.
  19. 19. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM. Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem. 2001;276(36):34167–74. pmid:11445576.
  20. 20. Takahashi M, Kamei Y, Ezaki O. Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size. Am J Physiol Endocrinol Metab. 2005;288(1):E117–24. pmid:15353408.
  21. 21. Voigt A, Ribot J, Sabater AG, Palou A, Bonet ML, Klaus S. Identification of Mest/Peg1 gene expression as a predictive biomarker of adipose tissue expansion sensitive to dietary anti-obesity interventions. Genes & nutrition. 2015;10(5):477. pmid:26143179;
  22. 22. Bluher M. Adipose tissue dysfunction in obesity. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association. 2009;117(6):241–50. pmid:19358089.
  23. 23. Rutkowski JM, Stern JH, Scherer PE. The cell biology of fat expansion. The Journal of cell biology. 2015;208(5):501–12. pmid:25733711;
  24. 24. Holmquist M. Alpha/Beta-hydrolase fold enzymes: structures, functions and mechanisms. Curr Protein Pept Sci. 2000;1(2):209–35. pmid:12369917.
  25. 25. Ollis DL, Cheah E, Cygler M, Dijkstra B, Frolow F, Franken SM, et al. The alpha/beta hydrolase fold. Protein Eng. 1992;5(3):197–211. pmid:1409539.
  26. 26. Carter P, Wells JA. Dissecting the catalytic triad of a serine protease. Nature. 1988;332(6164):564–8. Epub 1988/04/07. pmid:3282170.
  27. 27. Jung H, Lee SK, Jho EH. Mest/Peg1 inhibits Wnt signalling through regulation of LRP6 glycosylation. The Biochemical journal. 2011;436(2):263–9. pmid:21375506.
  28. 28. Decker M, Arand M, Cronin A. Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Arch Toxicol. 2009;83(4):297–318. Epub 2009/04/03. pmid:19340413.
  29. 29. Kaneko-Ishino T, Kuroiwa Y, Miyoshi N, Kohda T, Suzuki R, Yokoyama M, et al. Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nature genetics. 1995;11(1):52–9. pmid:7550314.
  30. 30. Cowart LA, Wei S, Hsu MH, Johnson EF, Krishna MU, Falck JR, et al. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J Biol Chem. 2002;277(38):35105–12. Epub 2002/07/19. pmid:12124379.
  31. 31. Fang X, Hu S, Watanabe T, Weintraub NL, Snyder GD, Yao J, et al. Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors. J Pharmacol Exp Ther. 2005;314(1):260–70. Epub 2005/03/31. pmid:15798002.
  32. 32. Fang X, Hu S, Xu B, Snyder GD, Harmon S, Yao J, et al. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. Am J Physiol Heart Circ Physiol. 2006;290(1):H55–63. Epub 2005/08/23. pmid:16113065.
  33. 33. Spector AA. Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res. 2009;50 Suppl:S52–6. Epub 2008/10/28. pmid:18952572.
  34. 34. Spector AA, Norris AW. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol. 2007;292(3):C996–1012. Epub 2006/09/22. pmid:16987999.
  35. 35. Zha W, Edin ML, Vendrov KC, Schuck RN, Lih FB, Jat JL, et al. Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity. J Lipid Res. 2014;55(10):2124–36. pmid:25114171;
  36. 36. Kim DH, Vanella L, Inoue K, Burgess A, Gotlinger K, Manthati VL, et al. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma. Stem cells and development. 2010;19(12):1863–73. pmid:20412023;
  37. 37. Waldman M, Bellner L, Vanella L, Schragenheim J, Sodhi K, Singh SP, et al. Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1alpha Activation, Which Is Required for HO-1 Expression and Increased Mitochondrial Function. Stem cells and development. 2016;25(14):1084–94. pmid:27224420;
  38. 38. El Hajj N, Pliushch G, Schneider E, Dittrich M, Muller T, Korenkov M, et al. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes. 2013;62(4):1320–8. pmid:23209187;
  39. 39. Soubry A, Murphy SK, Wang F, Huang Z, Vidal AC, Fuemmeler BF, et al. Newborns of obese parents have altered DNA methylation patterns at imprinted genes. International journal of obesity. 2015;39(4):650–7. pmid:24158121;
  40. 40. Barbagallo I, Vanella L, Cambria MT, Tibullo D, Godos J, Guarnaccia L, et al. Silibinin Regulates Lipid Metabolism and Differentiation in Functional Human Adipocytes. Frontiers in pharmacology. 2015;6:309. pmid:26834634;
  41. 41. Karbiener M, Glantschnig C, Pisani DF, Laurencikiene J, Dahlman I, Herzig S, et al. Mesoderm-specific transcript (MEST) is a negative regulator of human adipocyte differentiation. International journal of obesity. 2015;39(12):1733–41. pmid:26119994;
  42. 42. Kanwar YS, Kumar A, Ota K, Lin S, Wada J, Chugh S, et al. Identification of developmentally regulated mesodermal-specific transcript in mouse embryonic metanephros. Am J Physiol Renal Physiol. 2002;282(5):F953–65. pmid:11934706.
  43. 43. Lefebvre L, Viville S, Barton SC, Ishino F, Keverne EB, Surani MA. Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nature genetics. 1998;20(2):163–9. pmid:9771709.
  44. 44. Lefebvre L, Viville S, Barton SC, Ishino F, Surani MA. Genomic structure and parent-of-origin-specific methylation of Peg1. Human molecular genetics. 1997;6(11):1907–15. pmid:9302270.
  45. 45. Tada M, Tada T, Lefebvre L, Barton SC, Surani MA. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. The EMBO journal. 1997;16(21):6510–20. pmid:9351832.
  46. 46. Kamei Y, Suganami T, Kohda T, Ishino F, Yasuda K, Miura S, et al. Peg1/Mest in obese adipose tissue is expressed from the paternal allele in an isoform-specific manner. FEBS letters. 2007;581(1):91–6. Epub 2006/12/22. pmid:17182038.
  47. 47. Nakanishi N, Nakagawa Y, Tokushige N, Aoki N, Matsuzaka T, Ishii K, et al. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochemical and biophysical research communications. 2009;385(4):492–6. pmid:19460359.
  48. 48. Zhu L, Chen L, Shi CM, Xu GF, Xu LL, Zhu LL, et al. MiR-335, an adipogenesis-related microRNA, is involved in adipose tissue inflammation. Cell biochemistry and biophysics. 2014;68(2):283–90. pmid:23801157.
  49. 49. Dorn C, Riener MO, Kirovski G, Saugspier M, Steib K, Weiss TS, et al. Expression of fatty acid synthase in nonalcoholic fatty liver disease. International journal of clinical and experimental pathology. 2010;3(5):505–14. pmid:20606731;
  50. 50. Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepaa AL, et al. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes. 2009;58(1):203–8. pmid:18952834;
  51. 51. Miyazaki M, Dobrzyn A, Sampath H, Lee SH, Man WC, Chu K, et al. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha. J Biol Chem. 2004;279(33):35017–24. pmid:15180999.
  52. 52. Villanueva CJ, Monetti M, Shih M, Zhou P, Watkins SM, Bhanot S, et al. Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids. Hepatology. 2009;50(2):434–42. pmid:19472314;
  53. 53. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A. Adipogenesis and WNT signalling. Trends in endocrinology and metabolism: TEM. 2009;20(1):16–24. pmid:19008118;
  54. 54. Fuster JJ, Zuriaga MA, Ngo DT, Farb MG, Aprahamian T, Yamaguchi TP, et al. Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes. 2015;64(4):1235–48. pmid:25352637;
  55. 55. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, et al. Inhibition of adipogenesis by Wnt signaling. Science. 2000;289(5481):950–3. pmid:10937998.
  56. 56. Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado Jde D, Popovich PG, Partida-Sanchez S, et al. Novel Markers to Delineate Murine M1 and M2 Macrophages. PLoS One. 2015;10(12):e0145342. pmid:26699615;
  57. 57. Rim JS, Mynatt RL, Gawronska-Kozak B. Mesenchymal stem cells from the outer ear: a novel adult stem cell model system for the study of adipogenesis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2005;19(9):1205–7. pmid:15857881.
  58. 58. Chen YQ, Kuo MS, Li S, Bui HH, Peake DA, Sanders PE, et al. AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase. J Biol Chem. 2008;283(15):10048–57. pmid:18238778;
  59. 59. Beigneux AP, Vergnes L, Qiao X, Quatela S, Davis R, Watkins SM, et al. Agpat6—a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium. J Lipid Res. 2006;47(4):734–44. pmid:16449762;
  60. 60. Jura M, Jaroslawska J, Chu DT, Kozak LP. Mest and Sfrp5 are biomarkers for healthy adipose tissue. Biochimie. 2016;124:124–33. pmid:26001362.
  61. 61. Kumar RA, Chan KL, Wong AH, Little KQ, Rajcan-Separovic E, Abrahams BS, et al. Unexpected embryonic stem (ES) cell mutations represent a concern in gene targeting: lessons from "fierce" mice. Genesis. 2004;38(2):51–7. pmid:14994267.
  62. 62. Ineson J, Stayner C, Hazlett J, Slobbe L, Robson E, Legge M, et al. Somatic reactivation of expression of the silent maternal Mest allele and acquisition of normal reproductive behaviour in a colony of Peg1/Mest mutant mice. The Journal of reproduction and development. 2012;58(4):490–500. pmid:22522229.
  63. 63. Lin X, Wu L, Zhang Z, Yang R, Guan Q, Hou X, et al. MiR-335-5p promotes chondrogenesis in mouse mesenchymal stem cells and is regulated through two positive feedback loops. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2014;29(7):1575–85. pmid:24347469.
  64. 64. Hiramuki Y, Sato T, Furuta Y, Surani MA, Sehara-Fujisawa A. Mest but Not MiR-335 Affects Skeletal Muscle Growth and Regeneration. PLoS One. 2015;10(6):e0130436. pmid:26098312;
  65. 65. Anunciado-Koza RP, Higgins DC, Koza RA. Adipose tissue Mest and Sfrp5 are concomitant with variations of adiposity among inbred mouse strains fed a non-obesogenic diet. Biochimie. 2016;124:134–40. pmid:26005096;
  66. 66. Asterholm IW, Halberg N, Scherer PE. Mouse Models of Lipodystrophy Key reagents for the understanding of the metabolic syndrome. Drug discovery today Disease models. 2007;4(1):17–24. pmid:18193096;
  67. 67. Huang-Doran I, Sleigh A, Rochford JJ, O'Rahilly S, Savage DB. Lipodystrophy: metabolic insights from a rare disorder. The Journal of endocrinology. 2010;207(3):245–55. pmid:20870709.
  68. 68. Park SY, Choi GH, Choi HI, Ryu J, Jung CY, Lee W. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats. Archives of biochemistry and biophysics. 2005;436(2):276–84. pmid:15797240.
  69. 69. Pires RC, Souza EE, Vanzela EC, Ribeiro RA, Silva-Santos JC, Carneiro EM, et al. Short-term calorie restriction improves glucose homeostasis in old rats: involvement of AMPK. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 2014;39(8):895–901. pmid:24844367.
  70. 70. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444(7121):847–53. pmid:17167472;
  71. 71. Stanford KI, Middelbeek RJ, Townsend KL, An D, Nygaard EB, Hitchcox KM, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. The Journal of clinical investigation. 2013;123(1):215–23. pmid:23221344;
  72. 72. Weiss EP, Racette SB, Villareal DT, Fontana L, Steger-May K, Schechtman KB, et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. The American journal of clinical nutrition. 2006;84(5):1033–42. pmid:17093155;
  73. 73. Zietak M, Kovatcheva-Datchary P, Markiewicz LH, Stahlman M, Kozak LP, Backhed F. Altered Microbiota Contributes to Reduced Diet-Induced Obesity upon Cold Exposure. Cell metabolism. 2016;23(6):1216–23. pmid:27304513;
  74. 74. Wilfling F, Wang H, Haas JT, Krahmer N, Gould TJ, Uchida A, et al. Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. Developmental cell. 2013;24(4):384–99. pmid:23415954;
  75. 75. Cheng XY, Huang WJ, Hu SC, Zhang HL, Wang H, Zhang JX, et al. A global characterization and identification of multifunctional enzymes. PLoS One. 2012;7(6):e38979. pmid:22723914;
  76. 76. Lenfant N, Hotelier T, Velluet E, Bourne Y, Marchot P, Chatonnet A. ESTHER, the database of the alpha/beta-hydrolase fold superfamily of proteins: tools to explore diversity of functions. Nucleic acids research. 2013;41(Database issue):D423–9. pmid:23193256;
  77. 77. Marchot P, Chatonnet A. Enzymatic activity and protein interactions in alpha/beta hydrolase fold proteins: moonlighting versus promiscuity. Protein and peptide letters. 2012;19(2):132–43. pmid:21933125.
  78. 78. Vergnes L, Beigneux AP, Davis R, Watkins SM, Young SG, Reue K. Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J Lipid Res. 2006;47(4):745–54. pmid:16436371;
  79. 79. Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, Lee E, et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A. 1996;93(12):5860–5. pmid:8650183;
  80. 80. Zemany L, Kraus BJ, Norseen J, Saito T, Peroni OD, Johnson RL, et al. Downregulation of STRA6 in adipocytes and adipose stromovascular fraction in obesity and effects of adipocyte-specific STRA6 knockdown in vivo. Molecular and cellular biology. 2014;34(6):1170–86. pmid:24421389;
  81. 81. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A. 2002;99(10):6567–72. pmid:12011421;
  82. 82. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116–21. pmid:11309499;
  83. 83. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57(1):289–300.